Skip to main content
. 2017 Nov 10;17:745. doi: 10.1186/s12885-017-3674-x

Fig. 2.

Fig. 2

The expression status of miR-17-5p in clinical TNBC samples detected by In situ hybridization. a, c, Negative control of miR-17-5p in TNBC and adjacent non-tumour tissues. Positive expression of miR-17-5p in TNBC (d, e) and non-tumour tissues (b) was also presented. Scale bar, 10 μm